Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Pathology

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajpath.2011.03.004PMID 21703397PMCID PMC3123871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes.

  2011cited by this paper
• Oral treatment with a chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes

  2011cited by this paper
• Targeting the recruitment of monocytes and macrophages in renal disease.

  2010cited by this paper
• Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10.

  2010cited by this paper
• Cardiovascular , Pulmonary and Renal Pathology Late Onset of Ccl 2 Blockade with the Spiegelmer mNOX-E 36 – 3 PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db / db Mice

  2010cited by this paper
• Regeneration of glomerular podocytes by human renal progenitors.

  2009cited by this paper
• Recruitment of podocytes from glomerular parietal epithelial cells.

  2009cited by this paper
• New insights into the role of podocytes in proteinuria

  2009cited by this paper
• Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes

  2009cited by this paper
• Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.

  2008cited by this paper
• MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.

  2008cited by this paper
• From Fibrosis to Sclerosis

  2008cited by this paper
• Macrophage diversity in renal injury and repair.

  2008cited by this paper
• The role of chemokines and chemokine receptors in diabetic nephropathy.

  2008cited by this paper
• Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.

  2007cited by this paper
• Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice.

  2007cited by this paper
• Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches

  2007cited by this paper
• The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.

  2007cited by this paper
• Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice

  2007cited by this paper
• Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.

  2006cited by this paper
• Leukocyte recruitment and vascular injury in diabetic nephropathy.

  2006cited by this paper
• Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches.

  2006cited by this paper
• Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

  2006cited by this paper
• Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis.

  2005cited by this paper
• Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis

  2004cited by this paper
• Chemokines: multiple levels of leukocyte migration control.

  2004cited by this paper
• Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.

  2004cited by this paper
• The chemokine system in diverse forms of macrophage activation and polarization.

  2004cited by this paper
• Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

  2003cited by this paper
• Global and societal implications of the diabetes epidemic

  2001cited by this paper
• End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.

  1999cited by this paper
• Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.

  1999cited by this paper
• II. Incidence and prevalence of ESRD.

  1999cited by this paper

• Stromal Cell-Derived Factor-1, P-Selectin, and Advanced Oxidation Protein Products with Mitochondrial Dysfunction Concurrently Impact Cerebral Vessels in Patients with Normoalbuminuric Diabetic Kidney Disease and Type 2 Diabetes Mellitus

  2025cites this paper
• Copper metabolism-related biomarkers and therapeutic targets for diabetic nephropathy

  2025cites this paper
• Exploring macrophage heterogeneity in IgA nephropathy: Mechanisms of renal impairment and current therapeutic targets.

  2024cites this paper
• An inflammatory cytokine signature predicts IgA nephropathy severity and progression

  2024cites this paper
• The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial

  2024cites this paper
• Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1

  2023cites this paper
• Immunological Approaches in the Treatment of Diabetic Nephropathy.

  2023cites this paper
• Prognostic significance of plasma SDF-1 in acute ischemic stroke patients with diabetes mellitus: the CATIS trial

  2023cites this paper
• Mycophenolic acid directly protects podocytes by preserving the actin cytoskeleton and increasing cell survival

  2023cites this paper
• Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities.

  2022cites this paper
• Molecular Mechanisms of Kidney Injury and Repair

  2022cites this paper
• Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules

  2022cites this paper
• Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology

  2022cites this paper
• The role of chemokines in type 1 diabetes‐associated neuropathy

  2022cites this paper
• Fate and state transitions during human blood vessel organoid development

  2022cites this paper
• Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia

  2022cites this paper
• ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway

  2021cites this paper
• Serum stromal cell-derived factor-1 levels are associated with diabetic kidney disease in type 2 diabetic patients.

  2021cites this paper
• The recruitment mechanisms and potential therapeutic targets of podocytes from parietal epithelial cells

  2021cites this paper
• The Role of CXCL12 in Kidney Diseases: A Friend or Foe?

  2021cites this paper
• Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

  2020cites this paper
• Targeting Chemokine—Glycosaminoglycan Interactions to Inhibit Inflammation

  2020cites this paper
• The new biology of diabetic kidney disease - mechanisms and therapeutic implications.

  2020cites this paper
• Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy

  2020cites this paper
• Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

  2020cites this paper
• Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin.

  2020cites this paper
• Adipose specific aptamer adipo-8 recognizes and interacts with APMAP to ameliorates fat deposition in vitro and in vivo.

  2020cites this paper
• 2018 update in basic kidney research: fibrosis, inflammation, glomerular filtration and kidney disease progression.

  2019cites this paper
• Cellular and molecular mechanisms of kidney fibrosis.

  2019cites this paper
• Management of New Onset Diabetes: Time to Change Therapeutic Strategies

  2019cites this paper
• Time to Prevent the Development of Diabetic Nephropathy

  2019cites this paper
• Should We Change the Therapeutic Algorithm of Type 2 Diabetes Based on Accumulating Evidence?

  2019cites this paper
• Renal Injury Repair: How About the Role of Stem Cells.

  2019cites this paper
• CCL2/MCP‐1 and CXCL12/SDF‐1 blockade by L‐aptamers improve pancreatic islet engraftment and survival in mouse

  2019cites this paper
• Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes

  2019cites this paper
• Postnatal podocyte gain: Is the jury still out?

  2019cites this paper
• High levels of stromal cell-derived factor-1α predict short-term progression of renal dysfunction in patients with coronary artery disease

  2019cites this paper
• Awakening the Bowman: inhibition of CXCL12 signaling activates parietal epithelial cells.

  2018cites this paper
• Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines

  2018cites this paper
• Regenerating the kidney using human pluripotent stem cells and renal progenitors

  2018cites this paper
• Targeting inflammation in diabetic nephropathy: a tale of hope

  2018cites this paper
• CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism

  2018cites this paper
• CMC Aspects for the Clinical Development of Spiegelmers

  2018cites this paper
• Inflammatory Processes in Diabetic Glomeruli

  2018cites this paper
• Inflammation as a Potent Therapeutic Target for Interventions in Diabetic Nephropathy

  2018cites this paper
• The diabetes pandemic suggests unmet needs for ‘CKD with diabetes’ in addition to ‘diabetic nephropathy’—implications for pre-clinical research and drug testing

  2018cites this paper
• Can podocytes be regenerated in adults?

  2017cites this paper
• Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.

  2017cites this paper
• CXCL8 Antagonist Improves Diabetic Nephropathy in Male Mice With Diabetes and Attenuates High Glucose–Induced Mesangial Injury

  2017cites this paper
• Reprint of "Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis".

  2017cites this paper
• TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1&agr; (Chemokine Stromal Cell-Derived Factor-&agr;) Axis Suppresses Diabetic Retinopathy

  2017cites this paper
• Evolutionary trade-offs in kidney injury and repair.

  2017cites this paper
• Principles of Kidney Regeneration

  2017cites this paper
• Agarose Spot as a Comparative Method for in situ Analysis of Simultaneous Chemotactic Responses to Multiple Chemokines

  2017cites this paper
• New Insights into Podocyte Biology in Glomerular Health and Disease.

  2017cites this paper
• RNA Aptamer Delivery through Intact Human Skin.

  2017cites this paper
• Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease

  2017cites this paper
• Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.

  2016cites this paper
• Multiparametric Functional MRI: A Tool to Uncover Subtle Changes following Allogeneic Renal Transplantation

  2016cites this paper
• Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology

  2016cites this paper
• Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.

  2016cites this paper
• Evidence for Renal Progenitors in the Human Kidney

  2016cites this paper
• Biologic modulation in renal regeneration

  2016cites this paper
• Anti-inflammatory effects of gastric bypass surgery and their association with improvement in metabolic profile

  2015cites this paper
• SDF‐1/CXCR4/CXCR7 is pivotal for vascular smooth muscle cell proliferation and chronic allograft vasculopathy

  2015cites this paper
• Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance.

  2015cites this paper
• The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus Attenuation

  2015cites this paper
• Aptamer: “smart bomb” facilitates delivery of drugs to the cancer cells

  2015cites this paper
• Significance of CXCL12 in Type 2 Diabetes Mellitus and Its Associated Complications

  2015cites this paper
• Stem cell therapy for kidney disease

  2015cites this paper
• Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease

  2015cites this paper
• Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(®) therapeutics.

  2015cites this paper
• Outlook for aptamers after twenty five years.

  2015cites this paper
• Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases.

  2014cites this paper
• Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis

  2014cites this paper
• Atypical Presentations of Diabetic Nephropathy and Novel Therapies

  2014cites this paper
• Chronic Kidney Disease and Inflammation

  2014cites this paper
• The signaling pathway of stromal cell-derived factor-1 and its role in kidney diseases

  2014influential citation
• Renal progenitors and childhood: from development to disorders

  2014cites this paper
• Immune system modulation of kidney regeneration—mechanisms and implications

  2014cites this paper
• Stromal Cell-Derived Factor 1 Gene Polymorphism Is Associated with Susceptibility to Adverse Long-Term Allograft Outcomes in Non-Diabetic Kidney Transplant Recipients

  2014cites this paper
• Therapeutic approaches to diabetic nephropathy—beyond the RAS

  2014cites this paper
• Progenitor cells and podocyte regeneration.

  2014cites this paper
• Aptamers in immunological research.

  2014cites this paper
• Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli

  2014cites this paper
• Aptamers as Both Drugs and Drug-Carriers

  2014cites this paper
• Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics

  2014cites this paper
• Role of chemokines in proteinuric kidney disorders

  2014cites this paper
• Metabolic Effects of Bariatric Surgery: A Focus on Inflammation and Diabetic Kidney Disease

  2013cites this paper
• Quadruplex Nucleic Acids

  2013cites this paper
• Renal progenitors in non-diabetic and diabetic nephropathies.

  2013cites this paper
• Binding of a structured D-RNA molecule by an L-RNA aptamer.

  2013cites this paper
• Glomerular parietal epithelial cells in kidney physiology, pathology, and repair

  2013cites this paper
• Development of RNA aptamer-based therapeutic agents.

  2013cites this paper
• Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.

  2013cites this paper
• The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation.

  2013cites this paper
• The danger control concept in kidney disease: mesangial cells.

  2013cites this paper
• Dose-dependent association of smoking and bronchial hyperresponsiveness

  2013cites this paper
• SDF-1α reduces fibronectin expression in rat mesangial cells induced by TGF-β1 and high glucose through PI3K/Akt pathway.

  2013cites this paper
• Halting metastasis through CXCR4 inhibition.

  2013cites this paper